Search
for
Sort by
Research 21
- Efficacy and Safety of a Drinkable Nutraceutical in Premenopausal Women with Telogen Effluvium: A 6-Month, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
- A Novel, Drinkable Food Supplement Formulation Reduces Hair Shedding and Increases the Percentage of Anagen Scalp Hair Follicles in Females with Hair Loss
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Hair Aging Revisited: An Expert Delphi Consensus on Pathogenesis, Clinical Features, and Future Therapies
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Publicly Available Large Language Models for Trichoscopy: A Head-to-Head Comparison with Dermatologists
- An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration
- Molecular biology of hair morphogenesis: Development and cycling
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- p75 Neurotrophin Receptor Antagonist Retards Apoptosis-driven Hair Follicle Involution (Catagen)
- Biological activity of novel progesterone derivatives having a bulky ester side chains at C-3
- Pharmacology of Induced Artificial Platelets in Regenerative Medicine: Beyond Transfusion
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Experts’ view on the management of scalp seborrheic dermatitis in Italy
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.